NapiFeryn BioTech Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 18

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

NapiFeryn BioTech General Information

Description

Developer of a biorefinery plant technology designed to produce rapeseed protein from side streams of oil pressing. The company's platform uses a more sustainable and efficient process than traditional methods, resulting in a high-quality protein ideal for use in food and feed applications, enabling oil mills and food producers to develop natural bio proteins sustainably.

Contact Information

Website
www.napiferyn.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Ul. Dubois 114/116
  • Lodz, 93-465
  • Poland
+48 576
Primary Industry
Biotechnology
Other Industries
Food Products
Vertical(s)
Oil & Gas
Corporate Office
  • Ul. Dubois 114/116
  • Lodz, 93-465
  • Poland
+48 576

NapiFeryn BioTech Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

NapiFeryn BioTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
11. Secondary Transaction - Private 01-Aug-2026 Completed Generating Revenue
10. Later Stage VC 30-Jan-2023 Completed Generating Revenue
9. Grant 06-Aug-2020 Completed Generating Revenue
8. Grant 01-Feb-2019 Completed Generating Revenue
7. Grant 01-Jan-2019 Completed Generating Revenue
6. Accelerator/Incubator 14-Aug-2018 Completed Generating Revenue
5. Grant 01-Jul-2017 Completed Generating Revenue
4. Early Stage VC 01-Jan-2017 Completed Generating Revenue
3. Grant 01-Nov-2016 $2.97M $251K Completed Generating Revenue
2. Early Stage VC 19-Jan-2016 $251K $251K Completed Generating Revenue
To view NapiFeryn BioTech’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

NapiFeryn BioTech Patents

  • 35

    Total Documents Applications and Grants

  • Total Patents Families

  • 19

    Granted

  • 6

    Pending

  • Expiring in next 12 mo

NapiFeryn BioTech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4742915-A1 Low-fat plant meals containing aggregated plant globulins, plant-globulin-enriched products, and related processes Pending 13-Jul-2023
WO-2025012421-A1 Low-fat plant meals containing aggregated plant globulins, plant-globulin-enriched products, and related processes Inactive 13-Jul-2023
AU-2022277748-A1 Improved method for preparation of protein-enriched products from plant material Pending 17-May-2021
EP-4340629-A1 Improved method for preparation of protein-enriched products from plant material Pending 17-May-2021
US-20240225039-A1 Improved method for preparation of protein-enriched products from plant material Pending 17-May-2021 A23J1/144
To view NapiFeryn BioTech’s complete patent history, request access »

NapiFeryn BioTech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

NapiFeryn BioTech Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Icos Capital Venture Capital Minority
European Innovation Council Accelerator/Incubator Minority
EASME - EU Executive Agency for SMEs Corporation
EIT Food Accelerator/Incubator
Platformy Startowe Government
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

NapiFeryn BioTech FAQs

  • When was NapiFeryn BioTech founded?

    NapiFeryn BioTech was founded in 2014.

  • Where is NapiFeryn BioTech headquartered?

    NapiFeryn BioTech is headquartered in Lodz, Poland.

  • What is the size of NapiFeryn BioTech?

    NapiFeryn BioTech has 18 total employees.

  • What industry is NapiFeryn BioTech in?

    NapiFeryn BioTech’s primary industry is Biotechnology.

  • Is NapiFeryn BioTech a private or public company?

    NapiFeryn BioTech is a Private company.

  • What is NapiFeryn BioTech’s current revenue?

    The current revenue for NapiFeryn BioTech is .

  • How much funding has NapiFeryn BioTech raised over time?

    NapiFeryn BioTech has raised $2.93M.

  • Who are NapiFeryn BioTech’s investors?

    Icos Capital, European Innovation Council, EASME - EU Executive Agency for SMEs, EIT Food, and Platformy Startowe are 5 of 8 investors who have invested in NapiFeryn BioTech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process